Since 1961, when the existence of Stem Cells was proven accidentally, regenerative medicine has bloomed, shrunk, contracted, been hated and misunderstood all at once.
In 2008, the Stem Cells and Regenerative Medicine Congress had its inaugural year in the United States. Combined with President Obama’s promise to move the regenerative medicine industry forward, the event has grown year after year to become the premier event for those active in this space.
At this year’s event the regenerative medicine industry is taking it to the next level and discussing how genomics is changing the field – and highlighting the commercialization and manufacturing stories that have helped spur the recent success.
Discover the future of the regenerative medicine industry with exclusive content.
Regenerative medicine isn’t just a story about science, it is a story about people. That story is just starting to get good. Personalized medicine? Regenerative medicine has been doing it for years. It’s about time the rest of the industry caught up.
Discuss the hottest industry topics and make new connections
Learn from the best and brightest in the industry.
With networking drinks receptions, 1-2-1 partnering, a networking app and speed networking... we've got it all! Take part in a variety of formal and informal opportunities.
Contact us today to secure your position as a partner, sponsor or exhibitor at the show.
This event is an opportunity to showcase your services to your target market. By sponsoring our event, you can develop relationships, make sales and raise your company's profile.
Sponsoring involves more than just a two day event. We have access to the Total BioPharma community of almost 250,000 people. You provide us with great content, and we'll distribute it through email, our blog and multiple social media channels.
Your success at the show is dependent on the quality relationships you build. Take a look at the delegate list before the event, decide who you want to meet and we'll make it happen.
At the 2014 Drug Safety Congress Europe event, Alan Hochberg, F Hoffmann La-Roche AG, gave the presentation “Vigilance in Pharmacovigilance: Human Factors and Attention.” Download ...
The post Vigilance in Pharmacovigilance: Human Factors and Attention appeared first on Total Biopharma.
Dr Jaap Boelens, Pediatric Oncologist at the University of Utrecht has also been working on developing multiple treatments using cord blood. One of which involves ...
The post New uses for Cord Blood as an immunotherapy and in the treatment of lysosomal storage disease appeared first on Total Biopharma.
In 3 weeks, London will welcome over 80 leading international speakers to the 10th annual World Stem Cells & Regenerative Medicine Congress. Ahead of then ...
The post NEW Leading industry insights from stem cells & regenerative medicine professionals appeared first on Total Biopharma.
Innovation and strategy for pharmaceutical, biotech and R&D